This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Neutropenia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy)
    • mortality rates ranging between 2% and 21% have been reported in adults. Aggressive use of inpatient intravenous antibiotic therapy has reduced morbidity and mortality rates and intensive care management is now needed in fewer than 5% of cases in England. Systemic therapies to treat cancer can suppress the ability of bone marrow to respond to infection. This is particularly the case with systemic chemotherapy, although radiotherapy can also cause such suppression.

Neutropaenia:

  • normal adult peripheral blood absolute neutrophil count is 2.0-7.5 x 10^9/l - this is influenced by physical activity, age, genetic factors
  • neutropaenia is an absolute neutrophil count less than 1.5 x 10^9/l (1)
  • agranulocytosis implies a complete absence of neutrophils in the peripheral blood - however, in practice, the term is used to describe neutropaenia that is particularly severe (< 0.3 x 10^9/l)

A neutrophils count of less than 1.5 x 10^9/l may be due to:

  • decreased production
  • normal production but increased consumption

Presentation is usually with recurrent and prolonged infections which:

  • frequently involve the skin and mucous membranes
  • commonly are staphylococcal
  • may show minimal clinical features despite severe infection
  • are complicated by suppurative lymphadenopathy

A neutrophil count of <0.5 x 10^9/l requires immediate medical/haematological review. Asymptomatic patients require prophylactic antibiotic treatment (e.g. ciprofloxacin) because of risk of infection

When to refer patients in the community for suspected neutropenic sepsis

  • suspect neutropenic sepsis in patients having anticancer treatment who become unwell
  • refer patients with suspected neutropenic sepsis immediately for assessment in secondary or tertiary care

Starting antibiotic therapy (1)

  • beta lactam monotherapy with piperacillin with tazobactam as initial empiric antibiotic therapy should be offered to patients with suspected neutropenic sepsis who need intravenous treatment unless there are patient-specific or local microbiological contraindications
  • an aminoglycoside should not be offered, either as monotherapy or in dual therapy, for the initial empiric treatment of suspected neutropenic sepsis unless there are patient-specific or local microbiological indications

A suggested management of a low neutrophil count in an adult is presented (3):

 

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.